Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria

被引:5
|
作者
Cosmas, Nanma T. [1 ]
Nimzing, Lohya [1 ,2 ]
Egah, Daniel [1 ,3 ]
Famooto, Ayo [4 ]
Adebamowo, Sally N. [5 ,6 ]
Adebamowo, Clement A. [4 ,5 ,6 ]
机构
[1] Univ Jos, Coll Hlth Sci, Dept Med Microbiol, Jos, Nigeria
[2] Univ Jos, Coll Hlth Sci, Dept Med Lab Sci, Jos, Nigeria
[3] Jos Univ, Dept Med Microbiol, Teaching Hosp, Jos, Nigeria
[4] Inst Human Virol Nigeria, Abuja, Nigeria
[5] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 660 West Redmond St, Baltimore, MD 21201 USA
[6] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, 660 West Redmond St, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
Age-specific; Prevalence; HPV; Adolescent girls; HPV vaccine introduction; Jos Nigeria; HUMAN-PAPILLOMAVIRUS INFECTION; EARLY SEXUAL DEBUT; RISK-FACTORS; FEMALES;
D O I
10.1186/s12879-022-07215-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose Knowledge of the prevalence of HPV infection among adolescent and early adult girls is essential to determining the best age for the introduction of HPV vaccine, monitoring vaccine efficacy, and giving insight into determinants of persistent high-risk HPV infection, a necessary cause of cervical cancer. Yet, there have been limited studies of HPV infection among adolescent and early adult girls in low-and-middle-income countries. Methods In this cross-sectional study, we randomly selected 205 girls, aged 9-20 years, from 10 schools in central Nigeria. We obtained informed consent and assent, collected data, and trained participants to self-collect vaginal samples using swab stick. We genotyped HPV using SPF10-DEIA/LiPA(25) and analyzed data using Stata 14 (R). Results The mean (SD) age of the girls was 14.9 (2.3) years. We found HPV in 13.2% of vaginal swabs. The earliest age at which anyHPV and hrHPV infections were detected was 10 and 12 years respectively. The prevalence of any HPV peaked at 16 and 17 years, hrHPV at 16 years, lrHPV at 17 and 18 years and multiple hrHPV 18 years of age. The prevalence of hrHPV infection was 1.5% among the 9-12 years age group, 2.9% among 13-16 years and 3.4% among 17-20 years old. The commonest hrHPV types detected were 52 (3.9%), 18 (1.5%) and 51 (2.4%). The most common lrHPV types was 6 (2.9%). Conclusion The prevalence of HPV infection in these urbanized young girls in Nigeria is high and commences after 9 years of age. HPV vaccination in this population should start at 9 years of age or younger to prevent the establishment of persistent HPV infection. Key Messages The prevalence of HPV was 13.2% among adolescent girls in Jos, North-Central Nigeria. The earliest age at vaginal HPV infection was 11 years of age. The most predominant hrHPV type in vaginal swab was HPV 52. These findings point to the need for introduction of HPV vaccine starting at 9 years of age among girls in Nigeria to give maximum protection.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria
    Nanma T. Cosmas
    Lohya Nimzing
    Daniel Egah
    Ayo Famooto
    Sally N. Adebamowo
    Clement A. Adebamowo
    BMC Infectious Diseases, 22
  • [2] Age-specific HPV prevalence among adolescent girls in Jos, North-Central Nigeria
    Dashe, Nanma
    Nimzing, Lohya
    Egah, Daniel
    Adebamowo, Sally
    Adebamowo, Clement
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 : 77 - 77
  • [3] Dataset for vaginal human papillomavirus infection among adolescent and early adult girls in Jos, Nigeria
    Nanma T. Cosmas
    Lohya Nimzing
    Daniel Z. Egah
    Oluranti A. Famooto
    Sally N. Adebamowo
    Clement A. Adebamowo
    BMC Research Notes, 16
  • [4] Dataset for vaginal human papillomavirus infection among adolescent and early adult girls in Jos, Nigeria
    Cosmas, Nanma T.
    Nimzing, Lohya
    Egah, Daniel Z.
    Famooto, Oluranti A.
    Adebamowo, Sally N.
    Adebamowo, Clement A.
    BMC RESEARCH NOTES, 2023, 16 (01)
  • [5] Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria
    Ajen Stephen Anzaku
    Jonah Musa
    Archives of Gynecology and Obstetrics, 2013, 287 : 859 - 863
  • [6] Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria
    Anzaku, Ajen Stephen
    Musa, Jonah
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 287 (05) : 859 - 863
  • [7] Postpartum maternal morbidity in Jos, north-central Nigeria
    Mutihir, Josiah T.
    Utoo, B. T.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2011, 14 (01) : 38 - 42
  • [8] EXPERIENCE WITH RIGID ESOPHAGOSCOPY IN JOS, NORTH-CENTRAL NIGERIA
    Adoga, A. A.
    Adoga, A. S.
    Nwaorgu, O. G. B.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2009, 12 (03) : 237 - 239
  • [9] Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria
    Daniel, Grace O.
    Musa, Jonah
    Akindigh, Terver M.
    Shinku, Francis
    Shuaibu, Samaila, I
    Kwaghe, Barka
    Afolaranmi, Tolulope
    Okpala, Chidi
    Agbaji, Oche
    Sagay, Atiene
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 151 (02) : 253 - 259
  • [10] HIV Prevalence in Vulnerable Children Living in Jos, Plateau State, North-Central Nigeria
    Abok, I.
    Banwat, M.
    Oguche, S.
    Okolo, S. N.
    Zoakah, Ayuba
    INTERNATIONAL JOURNAL OF CHILD HEALTH AND NUTRITION, 2015, 4 (04): : 240 - 245